Glaxo Wellcome UK Ltd T/A GSK has informed the MHRA of an issue related to error in the decommissioning of a specified batch of Beconase Aqueous Nasal Spray. Upon decommissioning at the pharmacy and when scanning the serialised 2D code, the status of packs may report as ‘DESTROYED.’ Although there is no risk to product quality, any remaining stock should be quarantined and returned.
Further information, details of the affected batch and advice for healthcare professionals and wholesalers can be found on the MHRA website.